or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

Key Votes

HB 2684 - Limits the Use of Certain Abortion-Inducing Drugs to FDA Approved Protocol - Key Vote

Oklahoma Key Votes

Nathan Dahm voted Yea (Passage) on this Legislation.

Read statements Nathan Dahm made in this general time period.

Stages

Family

Issues

Stage Details

Legislation - Signed (Executive) -

Title: Limits the Use of Certain Abortion-Inducing Drugs to FDA Approved Protocol

Legislation - Bill Passed (Senate) (37-5) - (Key vote)

Title: Limits the Use of Certain Abortion-Inducing Drugs to FDA Approved Protocol

Vote Smart's Synopsis:

Vote to pass a bill that limits the use of abortion-inducing drugs to the FDA approved protocol, effective November 1, 2014.

Highlights:
  • Prohibits a physician from knowingly or recklessly failing to provide or prescribe an “abortion-inducing” drug according to the protocol authorized by the U.S. Food and Drug Administration and as outlined by the FDA-approved label, including the “Mifeprex Regimen” (Sec. 1).
  • Defines an “abortion-inducing drug” as a medicine, drug, or any other substance prescribed or dispensed with the intent of inducing an abortion, including but not limited to the “off-label” use of drugs (Sec. 1).
  • Defines “Mifeprex Regimen” as an abortion-inducing drug regimen that includes the administration of both mifepristone and misoprostol (Sec. 1).
Legislation - Bill Passed (House) (81-8) -
Legislation - Introduced (House) -

Title: Limits the Use of Certain Abortion-Inducing Drugs to FDA Approved Protocol

Sponsors

Co-sponsors

Back to top